These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 414816)

  • 1. Cell-mediated immune response in gonococcal infections.
    Wyle FA; Rowlett C; Blumenthal T
    Br J Vener Dis; 1977 Dec; 53(6):353-9. PubMed ID: 414816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell-mediated immune response to gonococcal antigen in uro-arthritis (Reiter's disease): (a) inhibition of migration of sensitised human lymphocytes, (b) lymphocyte transformation in vitro measured by 14C-thymidine uptake.
    Rosenthal L
    Scand J Rheumatol; 1976; 5(4):209-15. PubMed ID: 827017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VA-MENGOC-BC Vaccination Induces Serum and Mucosal Anti Neisseria gonorrhoeae Immune Responses and Reduces the Incidence of Gonorrhea.
    Reyes Díaz LM; Lastre González MSJB; Cuello M; Sierra-González VG; Ramos Pupo R; Lantero MI; Harandi AM; Black S; Pérez O
    Pediatr Infect Dis J; 2021 Apr; 40(4):375-381. PubMed ID: 33591079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neisserial antigen H.8 is immunogenic in patients with disseminated gonococcal and meningococcal infections.
    Black JR; Black WJ; Cannon JG
    J Infect Dis; 1985 Apr; 151(4):650-7. PubMed ID: 3919117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence of serum antibodies to Neisseria gonorrhoeae before gonococcal infection.
    Hicks CB; Boslego JW; Brandt B
    J Infect Dis; 1987 Jun; 155(6):1276-81. PubMed ID: 2883240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular immune responses during gonococcal and meningococcal infections.
    Cooper MD; Moticka EJ
    Clin Microbiol Rev; 1989 Apr; 2 Suppl(Suppl):S29-34. PubMed ID: 2497960
    [No Abstract]   [Full Text] [Related]  

  • 7. Quantitative determination of antibody to gonococcal pili. Changes in antibody levels with gonococcal infection.
    Buchanan TM; Swanson J; Holmes KK; Kraus SJ; Gotschlich EC
    J Clin Invest; 1973 Nov; 52(11):2896-909. PubMed ID: 4201268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the influence of antigens on the results with the gonococcal complement fixation test in patients with uncomplicated and complicated gonorrhoea.
    Sandström E; Danielsson D
    Acta Derm Venereol; 1977; 57(6):547-552. PubMed ID: 73333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enzyme-linked immunosorbent assays for the detection of Neisseria gonorrhoeae specific antibodies.
    Brodeur BR; Ashton FE; Diena BB
    Can J Microbiol; 1978 Nov; 24(11):1300-5. PubMed ID: 105793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-mediated immune response in gonococcal infection.
    Landolfo PJ; Marrie TJ; Nelson NA; Ronald AR
    Can J Microbiol; 1981 Jan; 27(1):76-80. PubMed ID: 6111387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunization with recombinant truncated Neisseria meningitidis-Macrophage Infectivity Potentiator (rT-Nm-MIP) protein induces murine antibodies that are cross-reactive and bactericidal for Neisseria gonorrhoeae.
    Humbert MV; Christodoulides M
    Vaccine; 2018 Jun; 36(27):3926-3936. PubMed ID: 29803329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transformation of lymphocytes in gonorrhea before and after therapy.
    Esquenazi V; Streitfeld MM
    Infect Immun; 1973 Oct; 8(4):503-9. PubMed ID: 4200538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody to Rmp (outer membrane protein 3) increases susceptibility to gonococcal infection.
    Plummer FA; Chubb H; Simonsen JN; Bosire M; Slaney L; Maclean I; Ndinya-Achola JO; Waiyaki P; Brunham RC
    J Clin Invest; 1993 Jan; 91(1):339-43. PubMed ID: 8423230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neisseria proteomics for antigen discovery and vaccine development.
    Christodoulides M
    Expert Rev Proteomics; 2014 Oct; 11(5):573-91. PubMed ID: 25017717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Class specific antibody response to gonococcal infection.
    Miettinen A; Hakkarainen K; Grönroos P; Heinonen P; Teisala K; Aine R; Sillantaka I; Saarenmaa K; Lehtinen M; Punnonen R
    J Clin Pathol; 1989 Jan; 42(1):72-6. PubMed ID: 2564006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement interactions with the pathogenic Neisseriae: clinical features, deficiency states, and evasion mechanisms.
    Lewis LA; Ram S
    FEBS Lett; 2020 Aug; 594(16):2670-2694. PubMed ID: 32058583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modified immunofluorescence test for the serologic diagnosis of gonorrhea (FGT-ABS).
    Gaafar HA; Schoonmaker D
    Sex Transm Dis; 1977; 4(2):44-8. PubMed ID: 410113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunity to gonococcal infection induced by vaccination with isolated outer membranes of Neisseria gonorrhoeae in guinea pigs.
    Buchanan TM; Arko RJ
    J Infect Dis; 1977 Jun; 135(6):879-87. PubMed ID: 405431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aseptic arthritis after gonorrhoea.
    Rosenthal L; Olhagen B; Ek S
    Ann Rheum Dis; 1980 Apr; 39(2):141-6. PubMed ID: 6770765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the antigen-antibody specificity in the semen of patients with Neisseria gonorrhoeae.
    Zheng H
    Chin Med Sci J; 1997 Mar; 12(1):47-9. PubMed ID: 11243099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.